We have previously demonstrated that TAK1 inhibition by LLZ reduced joint inflammation and bone destruction by inhibiting NLRP3 inflammasome and TNF-α expression in collagen-induced arthritis, a mouse model of rheumatoid arthritis [8]. Here, TNF is linked to rheumatoid arthritis.